Joshua R. Disbrow is Chief Executive Officer of AYTU BIOPHARMA, INC. Currently has a direct ownership of 71,591 shares of AYTU, which is worth approximately $114,545. The most recent transaction as insider was on Jun 14, 2023, when has been sold 14,000 shares (Common Shares) at a price of $1.86 per share, resulting in proceeds of $26,040. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 71.6K
0% 3M change
0% 12M change
Total Value Held $114,545

Joshua R. Disbrow Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2023
BUY
Open market or private purchase
$26,040 $1.86 p/Share
14,000 Added 16.36%
71,591 Common Shares
Dec 20 2022
SELL
Sale (or disposition) back to the issuer
-
80,000 Reduced 6.49%
1,151,877 Common Stock
Dec 19 2022
BUY
Open market or private purchase
$24,721 $0.22 p/Share
112,371 Added 8.36%
1,231,877 Common Stock
Nov 18 2022
BUY
Grant, award, or other acquisition
$53,280 $0.24 p/Share
222,000 Added 16.55%
1,119,506 Common Shares
Apr 16 2021
BUY
Grant, award, or other acquisition
-
800,000 Added 47.13%
897,506 Common Stock

Also insider at

ZYXI
ZYNEX INC Healthcare
JRD

Joshua R. Disbrow

Chief Executive Officer
Englewood, CO

Track Institutional and Insider Activities on AYTU

Follow AYTU BIOPHARMA, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AYTU shares.

Notify only if

Insider Trading

Get notified when an Aytu Biopharma, Inc insider buys or sells AYTU shares.

Notify only if

News

Receive news related to AYTU BIOPHARMA, INC

Track Activities on AYTU